Key result
Elevated 24-hour systolic BP variability linked to ~112% greater diabetic microangiopathy risk in T2DM.
Why the study?
The study was conducted to analyze the relationship between blood pressure variability and diabetic microangiopathy in patients with type 2 diabetes mellitus.
Is blood pressure variability associated with the occurrence of diabetic microangiopathy in patients with type 2 diabetes mellitus?
Cross-Sectional (n=240)
No
Is blood pressure variability associated with the occurrence of diabetic microangiopathy in patients with type 2 diabetes mellitus?
Elevated blood pressure variability, particularly 24-hour and daytime systolic BPV, is strongly associated with the presence of diabetic microangiopathy in type 2 diabetes.
Answers are grounded in this paper and cite their sources.
May warrant BPV monitoring in T2DM; leaves open whether reducing variability prevents microangiopathy.
OBJECTIVES: This study analyzed the relationship between blood pressure variability (BPV) and diabetic microangiopathy (DMAP). METHODS: A total of 240 type 2 diabetes mellitus (T2DM) patients were selectively enrolled, including 161 patients with DMAP and 79 patients without DMAP. Clinical baseline data were collected, and 24-h systolic BPV (24hSBPV), 24-h diastolic BPV (24hDBPV), daytime systolic BPV (dSBPV), daytime diastolic BPV (dDBPV), nighttime systolic BPV (nSBPV) and nighttime diastolic BPV (nDBPV) were measured by ambulatory blood pressure monitoring. Diagnostic value of triglyceride (TG), urine albumin-to-creatinine ratio (UACR), DM duration, 24hSBPV, dSBPV and nDBPV for DMAP was analyzed by receiver operating characteristic curves. RESULTS: There were significant differences in DM duration, systolic blood pressure, high-density lipoprotein cholesterol, UACR, TG, glycosylated hemoglobin, 24hSBPV, 24hDBPV, dSBPV, dDBPV, nSBPV, nDBPV between DMAP and non-DMAP patients. All these BPV parameters were highest in diabetic nephropathy (DN) patients, while only 24hSBPV showed a significant difference between diabetic retinopathy and diabetic peripheral neuropathy patients. 24hSBPV (area under the curve [AUC] = 0.915, P < 0.001, cutoff = 8.28), dSBPV (AUC = 0.847, P < 0.001, cutoff = 8.54), nDBPV (AUC = 0.785, P < 0.001, cutoff = 11.13) and combined detection of 24hSBPV, dSBPV and nDBPV (AUC = 0.941, P < 0.001, cutoff = 0.611) had certain diagnostic value for DMAP. CONCLUSIONS: BPV is elevated in DMAP patients, with the highest BPV observed in DN patients. 24hSBPV, dSBPV, and nDBPV are associated with DMAP occurrence in T2DM patients, and may assist in diagnosing DMAP.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) conducted a cross-sectional in Type 2 diabetes mellitus (n=240). Blood pressure variability (BPV) vs. Low blood pressure variability was evaluated on Occurrence of diabetic microangiopathy (DMAP) associated with 24-hour systolic blood pressure variability (24hSBPV) (OR 2.115, 95% CI 1.594-2.806, p=<0.001). Elevated 24-hour systolic blood pressure variability was significantly associated with the occurrence of diabetic microangiopathy in patients with type 2 diabetes mellitus (OR 2.115).
Synapse has enriched 10 related papers. Consider them for comparative context: